Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Capital Reinvestment Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥233.18 Million) in capital expenditures (CN¥70.00 Million). Check 300702 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Tianyu Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Zhejiang Tianyu Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Zhejiang Tianyu Pharmaceutical Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025. See cash generation quality of Zhejiang Tianyu Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.76x | CN¥473.57 Million | CN¥357.77 Million | ▲ +54.1% |
| 2024 | 0.49x | CN¥344.64 Million | CN¥168.95 Million | ▼ -39.7% |
| 2020 | 0.81x | CN¥622.18 Million | CN¥506.05 Million | ▼ -1.7% |
| 2019 | 0.83x | CN¥427.84 Million | CN¥354.10 Million | ▼ -63.8% |
| 2018 | 2.29x | CN¥78.57 Million | CN¥179.89 Million | ▲ +80.1% |
| 2017 | 1.27x | CN¥88.52 Million | CN¥112.54 Million | ▲ +95.0% |
| 2016 | 0.65x | CN¥164.74 Million | CN¥107.44 Million | ▼ -84.6% |
| 2015 | 4.24x | CN¥14.75 Million | CN¥62.59 Million | ▲ +326.7% |
| 2014 | 0.99x | CN¥80.44 Million | CN¥79.99 Million | ▼ -42.2% |
| 2013 | 1.72x | CN¥39.73 Million | CN¥68.31 Million | — |